| The cancer genome atlas pan-cancer analysis project JN Weinstein, EA Collisson, GB Mills, KR Shaw, BA Ozenberger, K Ellrott, ... Nature genetics 45 (10), 1113-1120, 2013 | 7387 | 2013 |
| Pan-cancer analysis of whole genomes Nature 578 (7793), 82-93, 2020 | 2526* | 2020 |
| Multiplatform analysis of 12 cancer types reveals molecular classification within and across tissues of origin KA Hoadley, C Yau, DM Wolf, AD Cherniack, D Tamborero, S Ng, ... Cell 158 (4), 929-944, 2014 | 1605 | 2014 |
| Analyses of non-coding somatic drivers in 2,658 cancer whole genomes E Rheinbay, MM Nielsen, F Abascal, JA Wala, O Shapira, G Tiao, ... Nature 578 (7793), 102-111, 2020 | 585 | 2020 |
| Systemic fate of the adipocyte-derived factor adiponectin N Halberg, TD Schraw, ZV Wang, JY Kim, J Yi, MP Hamilton, ... Diabetes 58 (9), 1961-1970, 2009 | 233 | 2009 |
| SNHG16 is regulated by the Wnt pathway in colorectal cancer and affects genes involved in lipid metabolism LL Christensen, K True, MP Hamilton, MM Nielsen, ND Damas, ... Molecular oncology 10 (8), 1266-1282, 2016 | 174 | 2016 |
| Mitochondrial pyruvate import is a metabolic vulnerability in androgen receptor-driven prostate cancer DA Bader, SM Hartig, V Putluri, C Foley, MP Hamilton, EA Smith, PK Saha, ... Nature metabolism 1 (1), 70-85, 2019 | 169 | 2019 |
| Post-infusion CAR TReg cells identify patients resistant to CD19-CAR therapy Z Good, JY Spiegel, B Sahaf, MB Malipatlolla, ZJ Ehlinger, S Kurra, ... Nature medicine 28 (9), 1860-1871, 2022 | 155 | 2022 |
| Identification of a pan-cancer oncogenic microRNA superfamily anchored by a central core seed motif MP Hamilton, K Rajapakshe, SM Hartig, B Reva, MD McLellan, ... Nature communications 4 (1), 2730, 2013 | 119 | 2013 |
| Circular RNA expression is abundant and correlated to aggressiveness in early-stage bladder cancer TLH Okholm, MM Nielsen, MP Hamilton, LL Christensen, S Vang, ... NPJ genomic medicine 2 (1), 36, 2017 | 105 | 2017 |
| The miRNA interactome in metabolic homeostasis SM Hartig, MP Hamilton, DA Bader, SE McGuire Trends in Endocrinology & Metabolism 26 (12), 733-745, 2015 | 94 | 2015 |
| Determinants of resistance to engineered T cell therapies targeting CD19 in large B cell lymphomas BJ Sworder, DM Kurtz, SK Alig, MJ Frank, N Shukla, A Garofalo, ... Cancer cell 41 (1), 210-225. e5, 2023 | 83 | 2023 |
| Impact of Simvastatin on Adipose Tissue: Pleiotropic Effects in Vivo T Khan, MP Hamilton, DI Mundy, SC Chua, PE Scherer Endocrinology 150 (12), 5262-5272, 2009 | 73 | 2009 |
| Androgen receptor-modulatory microRNAs provide insight into therapy resistance and therapeutic targets in advanced prostate cancer CE Fletcher, E Sulpice, S Combe, A Shibakawa, DA Leach, MP Hamilton, ... Oncogene 38 (28), 5700-5724, 2019 | 71 | 2019 |
| miR-30a remodels subcutaneous adipose tissue inflammation to improve insulin sensitivity in obesity EH Koh, N Chernis, PK Saha, L Xiao, DA Bader, B Zhu, K Rajapakshe, ... Diabetes 67 (12), 2541-2553, 2018 | 71 | 2018 |
| Risk of second tumors and T-cell lymphoma after CAR T-cell therapy MP Hamilton, T Sugio, T Noordenbos, S Shi, PL Bulterys, CL Liu, X Kang, ... New England Journal of Medicine 390 (22), 2047-2060, 2024 | 66 | 2024 |
| The landscape of microRNA targeting in prostate cancer defined by AGO-PAR-CLIP MP Hamilton, KI Rajapakshe, DA Bader, JZ Cerne, EA Smith, C Coarfa, ... Neoplasia 18 (6), 356-370, 2016 | 61 | 2016 |
| Copy number gain of hsa-miR-569 at 3q26. 2 leads to loss of TP53INP1 and aggressiveness of epithelial cancers P Chaluvally-Raghavan, F Zhang, S Pradeep, MP Hamilton, X Zhao, ... Cancer Cell 26 (6), 863-879, 2014 | 56 | 2014 |
| Discovery and characterization of coding and non-coding driver mutations in more than 2,500 whole cancer genomes E Rheinbay, MM Nielsen, F Abascal, G Tiao, H Hornshøj, JM Hess, ... BioRxiv, 237313, 2017 | 47 | 2017 |
| Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples MH Bailey, WU Meyerson, LJ Dursi, LB Wang, G Dong, WW Liang, ... Nature communications 11 (1), 4748, 2020 | 45 | 2020 |